SARS-CoV-2 Infection in Iranian People Living with Human Immunodeficiency Virus-1 Infection
Author | Saba Garshasbi | en |
Author | Farah Bokharaei-Salim | en |
Author | Khadijeh Khanaliha | en |
Author | Seyed Jalal Kiani | en |
Author | Saeed Kalantari | en |
Author | Mahin Jamshidi Makiani | en |
Author | Arezoo Marjani | en |
Author | Farzaneh Dehghani-Dehej | en |
Author | Roghayeh Babaei | en |
Author | Mohsen Sadeghi | en |
Author | Mohammad Abbasi-Kolli | en |
Orcid | Saba Garshasbi [0000-0001-7564-7309] | en |
Orcid | Farah Bokharaei-Salim [0000-0002-5367-0847] | en |
Orcid | Khadijeh Khanaliha [0000-0003-3264-8496] | en |
Orcid | Seyed Jalal Kiani [0000-0002-5499-8924] | en |
Orcid | Saeed Kalantari [0000-0001-9896-4139] | en |
Orcid | Mahin Jamshidi Makiani [0000-0001-7052-5599] | en |
Orcid | Farzaneh Dehghani-Dehej [0000-0002-8440-7996] | en |
Orcid | Roghayeh Babaei [0000-0002-6203-8640] | en |
Orcid | Mohsen Sadeghi [0000-0002-9180-333X] | en |
Orcid | Mohammad Abbasi-Kolli [0000-0003-2661-9613] | en |
Issued Date | 2022-01-31 | en |
Abstract | Background: A novel Coronavirus first emerging in Wuhan, China, was named severe acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2). The disease caused by SARS‐CoV‐2 is known as Coronavirus disease 2019 (COVID‐19). HIV-1 infected individuals may be at risk of COVID-19. Objectives: This cross-sectional study evaluated the SARS-CoV-2 infection rate and COVID-19 prevalence among Iranian HIV-1-infected people. Methods: The study was conducted on 155 HIV-1-infected patients from June 2020 to October 2020. COVID-19 Ab (IgG) was detected using an enzyme immunoassay in serum specimens. Furthermore, nasopharyngeal and oropharyngeal specimens were collected. Then, the genomic RNA of SARS‐CoV‐2 was detected using a real-time polymerase chain reaction (RT-PCR). Clinical symptoms of the studied participants with and without COVID-19 were examined. Results: Of 155 HIV-1-infected individuals, 12 (7.7%) had positive real-time PCR results for SARS-CoV-2. Out of 12 (7.7%) patients with COVID‐19, four (33.3%) were males. Anti-COVID Ab (IgG) was detected in 10 (6.5%) participants, of whom eight (80.0%) were males. The most common COVID-19 clinical symptoms, including dry cough, fever, runny nose, anosmia, and hypogeusia, were observed in seven (58.3%), five (41.7%), five (41.7%), five (41.7%), and five (41.7%) patients with COVID-19, respectively. Conclusions: A recent study has shown that the risk of SARS‐CoV‐2 infection in HIV-infected individuals is similar to that in the general population. | en |
DOI | https://doi.org/10.5812/jjm.121929 | en |
Keyword | HIV-1 Infection | en |
Keyword | SARS-CoV-2 | en |
Keyword | COVID-19 | en |
Keyword | Clinical Symptoms | en |
Publisher | Brieflands | en |
Title | SARS-CoV-2 Infection in Iranian People Living with Human Immunodeficiency Virus-1 Infection | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jjm-15-1-121929.pdf
- Size:
- 161.18 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF